Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06162039 · ClinicalTrials.gov registry record
National Landscape of Hemorrhagic Myocardial Infarction in the United States
A clinical trial, sponsored by Rohan Dharmakumar.
- Completed
- Registry status
- 24,181
- Enrollment target
NCT06162039: Completed study, sponsored by Rohan Dharmakumar.
NCT06162039 is a clinical trial that has completed, run by Rohan Dharmakumar. The registered enrollment target is 24,181 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06162039 has completed, sponsored by Rohan Dharmakumar.
- COMPLETED
- Registry status
- 24,181 participants
- Enrollment target
Study Summary
Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States
Primary Outcome
Prevalence of Hemorrhagic Myocardial Infarction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24,181 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2025-03-15 |
What the finished NCT06162039 record still lists
NCT06162039 is an observational study that tracks outcomes without assigning an intervention. Its 24,181 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT06162039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06162039 about?
NCT06162039 is a clinical study titled "National Landscape of Hemorrhagic Myocardial Infarction in the United States". Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States
What is the current status of trial NCT06162039?
This trial is currently completed. The enrollment target is 24,181 participants. The study started on 2023-12-13. Estimated completion is 2025-03-15.
Who is sponsoring clinical trial NCT06162039?
This trial is sponsored by Rohan Dharmakumar, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
- NCT06589310 · 25,000 participants
Falcon Real World Evidence Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI